Evidence map›Paper›PMID 40973453›Full record

ArticleNucleic acids research2025

Absolute copy number aware CNV calling of sub-megabase segments in ultra-low coverage single-cell DNA sequencing data.

Solrun Kolbeinsdottir, Vasilios Zachariadis, Christian Sommerauer, Olli Lohi, Merja Heinäniemi, Martin Enge

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Solrun KolbeinsdottirDepartment of Oncology-Pathology Karolinska Institutet, Stockholm 171 77, Sweden.ORCID 0000-0001-7462-0278
Vasilios ZachariadisDepartment of Oncology-Pathology Karolinska Institutet, Stockholm 171 77, Sweden.
Christian SommerauerDepartment of Oncology-Pathology Karolinska Institutet, Stockholm 171 77, Sweden.
Olli LohiTampere Center for Child, Adolescent, and Maternal Health Research Faculty of Medicine and Health Technology, Tampere University, and Tays Cancer Centre Tampere University Hospital, Tampere 33520, Finland.
Merja HeinäniemiSchool of Medicine, University of Eastern Finland, Kuopio 70211, Finland.ORCID 0000-0003-0071-6802
Martin EngeDepartment of Oncology-Pathology Karolinska Institutet, Stockholm 171 77, Sweden.ORCID 0000-0001-8748-8931

Funding

Karolinska Institutet 2018-00963Research Council of Finland 321553Research Council of Finland 341540Research Council of Finland 341693Sigrid Juselius FoundationSwedish Cancer Society 210391Swedish Cancer Society 232839 PjSwedish Childhood Cancer Foundation MT2023-0014Swedish Childhood Cancer Foundation PR2024-0108Swedish Research Council 2023-02912
6 · The paper itself

Abstract

Recent advances in ultra-low coverage whole-genome sequencing (WGS) of single cells have enabled detailed analysis of copy number variation at a throughput approaching that of single-cell RNA sequencing. However, downstream computational methods have not seen comparable advances and are largely adaptations of deep sequencing methodology with reduced precision. Here, we present ASCENT, a computational method built to take full advantage of modern direct tagmentation-based WGS at ultra-low depth. Using joint segmentation with high-resolution bins, we accurately detect small segments, achieving accurate copy number profiles even at 100 000 reads per cell. ASCENT implements true absolute copy state inference for single cells, based on statistical modeling of coverage rather than comparison to a reference, while taking variable segment copy state into account. Further, ASCENT implements per-segment copy-neutral loss of heterozygosity (LOH) calling without the need for non-tumor or bulk WGS reference. When applied to a pediatric B-ALL sample, ASCENT finds copy-neutral LOH in a small segment and a minor subclone defined by breakpoints missed in bulk WGS. Thus, by applying appropriate computational methods, single-cell WGS provides clear advantages over bulk, even at a relatively low cell number and sequencing depth.

Indexed as

DNA Copy Number VariationsHigh-Throughput Nucleotide SequencingSequence Analysis, DNASingle-Cell AnalysisAlgorithmsHumansLoss of HeterozygositySoftwareWhole Genome Sequencing

Identifiers

PMID40973453
PMCPMC12449080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.